Isocoumarin
Alternative Names: PM 94128Latest Information Update: 10 Jul 2007
At a glance
- Originator PharmaMar
- Class Antineoplastics; Coumarins; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Oct 2004 Preclinical trials in Cancer in Spain (unspecified route)
- 25 Apr 2002 Phase-I clinical trials in Cancer in Spain (unspecified route)
- 07 Jul 1997 Preclinical development for Cancer in Spain (Unknown route)